Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (301-310 of 325) with videos related to

Pageof 33
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Emily P Hyle, Luke Ang, Grace Luu, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in MassachusettsAnne M Neilan, Elena Losina, Audrey C Bangs, et al.
HIV Clinical Trials|December 20, 2011
Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious DiseasesDavid W Haas, Daniel R Kuritzkes, Marylyn D Ritchie, et al.
Journal of the International AIDS Society|January 21, 2021
Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysisLorna Dunning, Aditya R Gandhi, Martina Penazzato, et al.
The Lancet. Global Health|July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of careEmily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
JAMA Network Open|December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 PandemicTravis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 PandemicTravis P Baggett, Justine A Scott, Mylinh H Le, et al.
The Journal of Infectious Diseases|December 1, 2025
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectivenessSujata E Tewari, Risa Hoffman, Shahin Lockman, et al.
JAMA Network Open|July 7, 2026
Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIVEmily P Hyle, Luke Ang, Grace Luu, et al.
The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.
Pageof 33

Showing results (301-310 of 325) with videos related to

Sort By:
Pageof 33
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
Costs associated with increasing numbers of Medicare beneficiaries with HIV aged 65 years and older from 2026 to 2035Emily P Hyle, Luke Ang, Grace Luu, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in MassachusettsAnne M Neilan, Elena Losina, Audrey C Bangs, et al.
HIV Clinical Trials|December 20, 2011
Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious DiseasesDavid W Haas, Daniel R Kuritzkes, Marylyn D Ritchie, et al.
Journal of the International AIDS Society|January 21, 2021
Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysisLorna Dunning, Aditya R Gandhi, Martina Penazzato, et al.
The Lancet. Global Health|July 25, 2025
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of careEmily P Hyle, Thulani Maphosa, Ajay Rangaraj, et al.
JAMA Network Open|December 22, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 PandemicTravis P Baggett, Justine A Scott, Mylinh H Le, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 PandemicTravis P Baggett, Justine A Scott, Mylinh H Le, et al.
The Journal of Infectious Diseases|December 1, 2025
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectivenessSujata E Tewari, Risa Hoffman, Shahin Lockman, et al.
JAMA Network Open|July 7, 2026
Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIVEmily P Hyle, Luke Ang, Grace Luu, et al.
The Lancet. Global Health|January 27, 2019
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling studyKrishna P Reddy, Ankur Gupta-Wright, Katherine L Fielding, et al.
Pageof 33